BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 21956158)

  • 1. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
    Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV
    Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
    Raju J; Patlolla JM; Swamy MV; Rao CV
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
    Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
    Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
    Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Rao CV; Seibert K
    Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Janakiram NB; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats.
    Janakiram NB; Mohammed A; Ravillah D; Choi CI; Zhang Y; Desai D; Amin S; Rao CV
    Oncol Rep; 2013 Aug; 30(2):952-60. PubMed ID: 23708609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models.
    Au A; Li B; Wang W; Roy H; Koehler K; Birt D
    Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells.
    Patlolla JM; Raju J; Swamy MV; Rao CV
    Mol Cancer Ther; 2006 Jun; 5(6):1459-66. PubMed ID: 16818504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in rats.
    Yasui Y; Suzuki R; Kohno H; Miyamoto S; Beppu F; Hosokawa M; Miyashita K; Tanaka T
    Nutr Cancer; 2007; 59(1):82-91. PubMed ID: 17927506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats.
    Ishikawa S; Asano T; Takenoshita S; Nozawa Y; Arihara K; Itoh M
    Nutr Res; 2009 Jan; 29(1):64-9. PubMed ID: 19185779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats.
    Tanaka T; Kohno H; Shimada R; Kagami S; Yamaguchi F; Kataoka S; Ariga T; Murakami A; Koshimizu K; Ohigashi H
    Carcinogenesis; 2000 Jun; 21(6):1183-9. PubMed ID: 10837008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
    Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
    Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-adenosyl L-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture.
    Guruswamy S; Swamy MV; Choi CI; Steele VE; Rao CV
    Int J Cancer; 2008 Jan; 122(1):25-30. PubMed ID: 17724725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial chemoprevention: efficacy of lovostatin and exisulind on the formation and progression of aberrant crypt foci.
    Kim KP; Whitehead C; Piazza G; Wargovich MJ
    Anticancer Res; 2004; 24(3a):1805-11. PubMed ID: 15274359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.